Jump to main content.

Iprodione Quickview (CASRN 36734-19-7)

Health assessment information on a chemical substance is included in IRIS only after a comprehensive review of toxicity data by U.S. EPA health scientists from several Program Offices, Regional Offices, and the Office of Research and Development.

Disclaimer: This QuickView represents a snapshot of key information. We suggest that you read the IRIS Summary to put this information into complete context.

For definitions of terms in the IRIS Web site, refer to the IRIS Glossary.

Status of Data for Iprodione

File First On-Line: 06/30/1988; Last Significant Revision: 06/30/1988

Category (section)
Last Revised
Oral RfD Assessment Yes 06/30/1988
Inhalation RfC Assessment No
Carcinogenicity Assessment No
  • 36734-19-7
  • 3-(3,5-Dichlorophenyl)-n-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide
  • FA 2071
  • Glycophene
  • 1-Imidazolidinecarboxamide, 3-(3,5-dichlorophenyl)-n-(1-methyl- ethyl)-2,4-dioxo-
  • 1-Isopropyl carbamoyl-3-(3,5-dichlorophenyl)-hydantoin
  • MRC 910
  • NRC 910
  • ROP 500 F
  • RP 26019
  • Chipco 26019
  • more...
Iprodione Source Documents
Chronic Health Hazard Assessments for Noncarcinogenic Effects

Reference Dose for Chronic Oral Exposure (RfD)

Critical Effect
Point of Departure*
Increased RBC Heinz bodies; decreased prostate weight NOEL : 4.2 mg/kg-day 100 4 x10-2 mg/kg-day

* The Point of Departure listed serves as a basis from which the Oral RfD was derived. See Discussion of Conversion Factors and Assumptions for more details.

Top of page

Reference Concentration for Chronic Inhalation Exposure (RfC)

Not Assessed under the IRIS Program.

Top of page

Carcinogenicity Assessment for Lifetime Exposure

Quantitative Estimate of Carcinogenic Risk from Oral Exposure

  • Not Assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure

  • Not Assessed under the IRIS Program.

Top of page

Recent Additions | Advanced Search | IRIS Home | Environmental Assessment | Research

Local Navigation

Jump to main content.